查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404747

数位治疗市场规模、份额、趋势分析报告：按应用、按最终用途、按地区、细分市场预测，2024-2030 年

Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, Smoking Cessation, Respiratory Diseases), By End-use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

数位治疗市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球数位治疗市场规模预计将达到325亿美元，2024年至2030年复合年增长率为27.2%。

智慧型手机的普及、数位医疗技术对医疗保健提供者和患者的成本效益以及对综合医疗保健系统和以患者为中心的护理不断增长的需求是市场的主要推动力。全球化和生活方式的改变，例如吸烟率增加、营养缺乏、缺乏运动和酒精成瘾增加，正在增加患慢性病的风险。拥有智慧型手机在增加全球连结方面逐渐变得越来越重要，从而在推动市场扩张方面发挥关键作用。

COVID-19 正在成为广泛采用数位治疗解决方案的催化剂。例如，Teladoc 报告称，与大流行前的水平相比，远端医疗的使用量增加了 38 倍。 FDA 等有影响力的监管机构采取的支持措施进一步推动了采用率的激增。例如，2020 年 4 月，美国FDA 发布了一份指导方针，旨在扩大为精神疾病患者设计的数位健康治疗设备的使用范围。同时，Kepios资料显示，全球网路用户数量年增率为 7.6%，平均每天新增 90 万新用户。虽然已开发国家和新兴经济体的智慧型手机和网路普及很高，但非洲和南亚等地区的经济较不发达，在普及落后。

然而，新兴国家对数位疗法的认识和理解有限以及患者资料隐私问题等挑战正在阻碍市场成长。数位疗法开发人员和製造商无法保证患者资料的安全性和机密性，导致消费者担忧。对资料隐私的担忧是数位疗法普及的主要障碍。对资料外洩以及透过科技遭受不必要的个人监视的可能性的担忧进一步阻碍了市场的成长。

儘管有这些挑战，数位疗法正在成为患有各种疾病的患者的重要治疗选择，这主要归功于主要行业参与者的个体化治疗计划和策略性倡议。这些努力包括收购、产品核可、产品发布和合作伙伴关係。此外，心臟病、糖尿病和焦虑症等慢性病的盛行率不断上升，迫使主要市场参与者投资数位治疗解决方案。目前许多製造商正在开发专门针对焦虑症的产品，并且有几种此类产品处于不同的开发阶段。这代表着巨大的市场成长机会。

数位治疗市场报告亮点

  • 从应用来看，由于市场参与者技术的快速进步，2023年糖尿病领域将占29.4%的市场占有率。预计该细分市场在 2024 年至 2030 年的预测期内也将出现最快的成长。
  • 由于患有慢性病的患者数量不断增加，2023年患者细分市场占据最大市场占有率，达到33.7%。数位疗法还可以帮助改善治疗的可及性，特别是对于农村和偏远地区的人们。
  • 由于对数位疗法的高需求，北美将在 2023 年占据市场主导地位。由于医疗保健意识的提高和数位健康产品的使用增加，预计这些区域市场在预测期内将表现出类似的趋势。
  • 2023 年 1 月，Omada Health 与 Intermountain Healthcare 的子公司 Castell 合作，扩大 Intermountain Healthcare 犹他医疗集团内患者获得糖尿病预防计画的机会。 Castell 将透过现有的护理途径识别和招募符合条件的患者，并提案护理协调员和提供者参与 Omada 的计划。
  • 2022 年 9 月，Limbix Health 与洛杉矶儿童医院 (CHLA) 合作推出了 SparkRx，这是一种自我管理的数位治疗方法，专为特定医疗机构中有忧郁症征兆的青少年（13-22 岁）而设计。我进行了调查。 SparkRx 专注于认知行为疗法 (CBT)，透过应对策略指导帮助青少年识别和管理忧郁症。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 数位治疗的变数、趋势与范围

  • 市场体系展望
    • 母市场分析
    • 附随市场前景
  • 市场动态
    • 市场驱动因素分析
    • 慢性病盛行率增加
    • 已开发国家和新兴国家智慧型手机普及不断提高
    • 数位医疗技术对医疗保健专业人员和患者的成本效益
    • 对综合医疗保健系统和以患者为中心的护理的需求不断增长
    • 市场抑制因素分析
    • 资料保护和隐私问题
    • 某些市场相关人员不愿意采用
    • 波特五力分析
    • 新进入者的威胁：低
    • 竞争公司之间的敌意：高
    • 替代品威胁：低
    • 买方议价能力：高
    • 供应商议价能力：低
    • PESTLE分析
    • 政治和法律
    • 经济和社会
    • 技术的
  • COVID-19 对数位疗法的影响

第 4 章 数位化治疗市场：使用量估算与趋势分析

  • 数位治疗市场：应用变化分析
  • 市场定义和范围
  • 按用途
  • 糖尿病
  • 肥胖
  • CVD
    • 禁止抽烟
  • 中枢神经系统疾病
  • 其他的

第五章数位治疗市场：最终用途估计与趋势分析

  • 数位治疗市场：最终用途变异分析
  • 市场定义和范围
  • 按最终用途
  • 病人
  • 提供者
  • 付款人
  • 雇主
  • 其他最终用途

第 6 章 数位治疗：按应用和最终用途分類的区域估计和趋势分析

  • 北美洲
    • 竞争场景
    • 2018-2030 年北美数位治疗市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 竞争场景
    • 2018-2030 年欧洲数位治疗市场估计与预测
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 竞争场景
    • 2018-2030 年亚太地区数位治疗市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 竞争场景
    • 2018-2030 年拉丁美洲数位治疗市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 竞争场景
    • 中东和非洲数位治疗市场估计和预测，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 科威特

第七章竞争分析

  • 热图分析
  • 参与企业
    • 公司分类分析

第八章 公司简介

  • OMADA Health, Inc.
  • Welldoc, Inc.
  • 2Morrow, Inc.
  • Teladoc Health, Inc.
  • Propeller Health
  • CANARY HEALTH
  • Noom, Inc.
  • Fitbit, LLC
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth, Corp.
  • GAIA AG
  • BigHealth
  • Limbix Health, Inc.
  • 玩家采用的主要策略是：
    • 扩张
    • 获得
    • 合作
    • 其他的
Product Code: GVR-1-68038-768-1

Digital Therapeutics Market Growth & Trends:

The global digital therapeutics market size is expected to reach USD 32.5 billion by 2030, exhibiting a CAGR of 27.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising adoption of smartphones, cost-effectiveness of digital health technology for healthcare providers and patients, and growing demand for integrated healthcare systems and patient-centered care primarily drive the market. Globalization and changing lifestyles, such as increased prevalence of smoking, poor nutrition, lack of exercise, and increased alcoholism, increases the risk of developing chronic diseases. Possessing a smartphone is progressively gaining significance in enhancing global connectivity, thereby playing a crucial role in propelling market expansion.

COVID-19 has acted as a catalyst for widespread adoption of digital therapeutics solutions. Teladoc, for example, reported a staggering 38-fold increase in telehealth usage compared to pre-pandemic levels. This surge in adoption was further bolstered by supportive measures implemented by influential regulatory bodies such as the FDA. An instance is issuance of guidelines by the U.S. FDA in April 2020 aimed at broadening the accessibility of digital health therapeutic devices designed for individuals with psychiatric conditions. In line with this, Kepios data reveals a global annual growth rate of 7.6% in number of internet users, equating to an average daily addition of 900,000 new users. Although developed and developing economies have achieved high smartphone and internet penetration, regions such as Africa and South Asia are experiencing slower progress due to their less advanced economies.

However, growth of the market is being impeded by challenges such as limited awareness and understanding of digital therapies in developing countries and concerns regarding patient data privacy. Developers and manufacturers of digital therapeutics have not been able to assure the security and confidentiality of patient data, leading to consumer apprehension. This fear regarding data privacy is a significant barrier to the widespread adoption of digital therapeutics. Concerns about data breaches and potential exposure to unwanted personal surveillance through technology further hinder market growth.

Despite these challenges, digital therapeutics has emerged as a crucial treatment option for patients with various medical conditions, primarily due to personalized treatment programs and the strategic initiatives taken by key industry players. These initiatives involve acquisitions, product approvals, product launches, and partnerships. Furthermore, the increasing prevalence of chronic diseases like heart disease, diabetes, and anxiety disorders has compelled major market players to invest in digital treatment solutions. Currently, numerous manufacturers are developing products specifically targeting anxiety disorders, and several such products are at different stages of development. This presents a significant opportunity for market growth.

Digital Therapeutics Market Report Highlights:

  • Based on application, the diabetes segment held the market share of 29.4% in 2023 owing to rapid technological advancements by market players. The segment is also expected to witness the fastest growth over the forecast period from 2024 to 2030
  • The patients segment held the largest market share of 33.7% in 2023, owing to the growing number of patients suffering from chronic conditions. Digital therapeutics can also help improve access to care for people, especially those from rural and remote areas
  • North America dominated the market in 2023 owing to the high demand for digital therapeutics in the region. These regional marketplaces are expected to show similar trends throughout the forecast period due to rising healthcare awareness coupled with increased use of digital health products over the forecast period
  • In January 2023, Omada Health partnered with Castell, an Intermountain Healthcare subsidiary, to expand access to its diabetes prevention program for patients under Intermountain Healthcare's Utah Medical Group. Castell will identify and enroll eligible patients through existing care pathways, with care coordinators and providers reaching out to offer participation in Omada programs
  • In September 2022, Limbix Health partnered with Children's Hospital Los Angeles (CHLA) to research SparkRx, a self-directed digital treatment designed for adolescents (ages 13-22) with signs of depression in specific medical care settings. SparkRx, centered on Cognitive Behavioral Therapy (CBT), assists teens in recognizing and managing depression through the teaching of coping mechanisms

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Research Process
    • 1.2.1 Information Procurement
  • 1.3 Research Scope and Assumptions
  • 1.4 Research Methodology
  • 1.5 Objectives
    • 1.5.1 Objective - 1
    • 1.5.2 Objective - 2
    • 1.5.3 Objective - 3
  • 1.6 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Executive Summary
  • 2.2 Digital Therapeutics Snapshot
  • 2.3 Digital Therapeutics Segment Snapshot
  • 2.4 Digital Therapeutics Competitive Landscape Snapshot

Chapter 3 Digital Therapeutics Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market analysis
    • 3.1.2 Ancillary market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.3 Increasing prevalence of chronic diseases
    • 3.2.4 Increasing smartphone penetration in developed and developing countries
    • 3.2.5 Cost-effectiveness of digital health technology for providers and patients
    • 3.2.6 Increasing demand for integrated healthcare systems and patient-centric care
    • 3.2.5 Market Restraint Analysis
    • 3.2.6 Concerns over data protection & privacy
    • 3.2.7 Reluctance in adoption by certain market stakeholders
    • 3.2.7 Porter Five Force Analysis
    • 3.2.8 Threat of New Entrants: Low
    • 3.2.9 Competitive Rivalry: High
    • 3.2.10 Threat of Substitutes: Low
    • 3.2.11 Bargaining Power of Buyers: High
    • 3.2.12 Bargaining Power of Suppliers: Low
    • 3.2.13 Pestle Analysis
    • 3.2.14 Political and legal
    • 3.2.15 Economical & Social
    • 3.2.16 Technological
  • 3.3 Impact of COVID-19 on the Digital Therapeutics

Chapter 4 Digital Therapeutics Market: Application Estimates & Trend Analysis

  • 4.1 Digital Therapeutics Market: Application Movement Analysis
  • 4.2 Market Definition and Scope
  • 4.3 Digital Therapeutics Market Estimates & Forecast, By Application (USD Million)
  • 4.4 Diabetes
  • 4.5 Obesity
  • 4.6 CVD
      • 4.7Smoking Cessation
  • 4.8 CNS Diseases
  • 4.9 OTHERS

Chapter 5 Digital Therapeutics Market: End-Use Estimates & Trend Analysis

  • 5.1 Digital Therapeutics Market: End-Use Movement Analysis
  • 5.2 Market Definition and Scope
  • 5.3 Digital Therapeutics Market Estimates & Forecast, By End-Use (USD Million)
  • 5.4 Patients
  • 5.5 Providers
  • 5.6 Payers
  • 5.7 Employers
  • 5.8 Other End-uses

Chapter 6 Digital Therapeutics: Regional Estimates & Trend Analysis, by Application, and End-Use

  • 6.1 North America
    • 6.1.1 Competitive Scenario
    • 6.1.2 North America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million):
    • 6.1.3 U.S.
      • 6.1.3.1 Key Country Dynamics
      • 6.1.3.2 Regulatory framework
      • 6.1.3.3 U.S. Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.4 Canada
      • 6.1.4.1 Key Country Dynamics
      • 6.1.4.2 Regulatory framework
      • 6.1.4.3 Canada Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2 Europe
    • 6.2.1 Competitive Scenario
    • 6.2.2 Europe Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 UK
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Regulatory framework
      • 6.2.3.3 UK Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Germany
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 Regulatory framework
      • 6.2.4.3 Germany Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 France
      • 6.2.5.1 Key Country Dynamics
      • 6.2.5.2 Regulatory framework
      • 6.2.5.3 France Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Spain
      • 6.2.6.1 Key Country Dynamics
      • 6.2.6.2 Regulatory framework
      • 6.2.6.3 Spain Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Italy
      • 6.2.7.1 Key Country Dynamics
      • 6.2.7.2 Regulatory framework
      • 6.2.7.2 Italy Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.8 Denmark
      • 6.2.8.1 Key Country Dynamics
      • 6.2.8.2 Regulatory framework
      • 6.2.8.3 Denmark Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.9 Sweden
      • 6.2.9.1 Key Country Dynamics
      • 6.2.9.2 Regulatory framework
      • 6.2.9.3 Sweden Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.10 Norway
      • 6.2.10.1 Key Country Dynamics
      • 6.2.10.2 Regulatory framework
      • 6.2.10.3 Norway Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Asia Pacific
    • 6.3.1 Competitive Scenario
    • 6.3.2 Asia Pacific Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Japan
      • 6.3.3.1 Key Country Dynamics
      • 6.3.3.2 Regulatory framework
      • 6.3.3.3 Japan Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 China
      • 6.3.4.1 Key Country Dynamics
      • 6.3.4.2 Regulatory framework
      • 6.3.4.3 China Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5 India
      • 6.3.5.1 Key Country Dynamics
      • 6.3.5.2 Regulatory framework
      • 6.3.5.3 India Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6 Australia
      • 6.3.6.1 Key Country Dynamics
      • 6.3.6.2 Regulatory framework
      • 6.3.6.3 Australia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7 South korea
      • 6.3.7.1 Key Country Dynamics
      • 6.3.7.2 Regulatory framework
      • 6.3.7.3 South korea Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8 Thailand
      • 6.3.8.1 Key Country Dynamics
      • 6.3.8.2 Regulatory framework
      • 6.3.8.3 ThailandDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Latin America
    • 6.4.1 Competitive Scenario:
    • 6.4.2 Latin America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Brazil
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 Regulatory framework
      • 6.4.3.3 BrazilDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 Mexico
      • 6.4.4.1 Key Country Dynamics
      • 6.4.4.2 Regulatory framework
      • 6.4.4.3 MexicoDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Argentina
      • 6.4.5.1 Key Country Dynamics
      • 6.4.5.2 Regulatory framework
      • 6.4.5.2 Argentina Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 MEA
    • 6.5.1 COMPETITIVE SCENARIO
    • 6.5.2 MEA Digital Therapeutics Market Estimates And ForecastsS, 2018 - 2030 (USD Million)
    • 6.5.3 South Africa
      • 6.5.3.1 Key Country Dynamics
      • 6.5.3.2 Regulatory framework
      • 6.5.3.3 South Africa Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 Saudi arabia
      • 6.5.4.1 Key Country Dynamics
      • 6.5.4.2 Regulatory framework
      • 6.5.4.3 Saudi arabia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5 UAE
      • 6.5.5.1 Key Country Dynamics
      • 6.5.5.2 Regulatory framework
      • 6.5.5.3 UAE Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6 Israel
      • 6.5.6.1 Key Country Dynamics
      • 6.5.6.2 Regulatory framework
      • 6.5.6.3 Israel Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7 Kuwait
      • 6.5.7.1 Key Country Dynamics
      • 6.5.7.2 Regulatory framework
      • 6.5.7.3 KuwaitDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Heat Map Analysis
  • 7.2 Participant Categorization
    • 7.2.1 Company Categorization Analysis

Chapter 8 Company Profile

  • 8.1. OMADA Health, Inc.
  • 8.2. Welldoc, Inc.
  • 8.3. 2Morrow, Inc.
  • 8.4. Teladoc Health, Inc.
  • 8.5. Propeller Health
  • 8.6. CANARY HEALTH
  • 8.7. Noom, Inc.
  • 8.8. Fitbit, LLC
  • 8.9. Pear Therapeutics, Inc.
  • 8.10. Akili Interactive Labs, Inc.
  • 8.11. HYGIEIA
  • 8.12. DarioHealth, Corp.
  • 8.13. GAIA AG
  • 8.14. BigHealth
  • 8.15. Limbix Health, Inc.
  • 8.16 Key Strategies Adopted by Players Include:
    • 8.16.1 Expansion
    • 8.16.2 Acquisition
    • 8.16.3 Collaborations
    • 8.16.4 Others 

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation
  • TABLE 3 North America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 4 North America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 5 North America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 7 U.S. macro dynamics
  • TABLE 8 U.S. digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 10 Canada macro dynamics
  • TABLE 11 Canada digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 12 Canada digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 13 Europe digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 14 Europe digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Europe digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 UK macro dynamics
  • TABLE 17 UK digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 18 UK digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany macro dynamics
  • TABLE 20 Germany digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 21 Germany digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 22 France macro dynamics
  • TABLE 23 France digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 24 France digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy macro dynamics
  • TABLE 26 Italy digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 27 Italy digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Spain macro dynamics
  • TABLE 29 Spain digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Spain digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 31 Denmark macro dynamics
  • TABLE 32 Denmark digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Denmark digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Sweden macro dynamics
  • TABLE 35 Sweden digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 36 Sweden digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 37 Norway macro dynamics
  • TABLE 38 Norway digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Norway digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 40 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 41 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 42 Asia Pacific digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018 - 2030 (USD Million)
  • TABLE 44 Japan macro dynamics
  • TABLE 45 Japan digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 46 Japan digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 China macro dynamics
  • TABLE 48 China digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 49 China digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 India macro dynamics
  • TABLE 51 India digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 52 India digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 53 Australia Macro dynamics
  • TABLE 54 Australia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 55 Australia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Thailand macro dynamics
  • TABLE 57 Thailand digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 58 Thailand digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea macro dynamics
  • TABLE 60 South Korea digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 62 Latin America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 63 Latin America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Latin America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 65 Brazil macro dynamics
  • TABLE 66 Brazil digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 67 Brazil digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 68 Mexico macro dynamics
  • TABLE 69 Mexico digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 70 Mexico digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 71 Argentina macro dynamics
  • TABLE 72 Argentina digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 73 Argentina digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 74 MEA digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 75 MEA digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 76 MEA digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 77 South Africa macro dynamics
  • TABLE 78 South Africa digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 79 South Africa digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 80 Saudi Arabia Macro dynamics
  • TABLE 81 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 82 Saudi Arabia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 83 UAE Macro dynamics
  • TABLE 84 UAE digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 85 UAE digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 86 Israel Macro dynamics
  • TABLE 87 Israel digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 88 Israel digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 89 Kuwait Macro dynamics
  • TABLE 90 Kuwait digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 92 Key companies undertaking expansions
  • TABLE 93 Key companies undertaking acquisitions
  • TABLE 94 Key companies undertaking collaborations

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Estimation methodology
  • FIG. 4 Data triangulation techniques
  • FIG. 5 Primary research pattern
  • FIG. 6 Market research approaches
  • FIG. 7 Value-chain-based sizing & forecasting
  • FIG. 8 QFD modeling for market share assessment
  • FIG. 9 Market formulation & validation
  • FIG. 10 Commodity flow analysis
  • FIG. 11 Digital therapeutics market snapshot, 2023 (USD Million)
  • FIG. 12 Segment snapshot
  • FIG. 13 Competitive landscape snapshot
  • FIG. 14 Parent market outlook
  • FIG. 15 Ancillary market outlook
  • FIG. 16 Digital Therapeutics market dynamics
  • FIG. 17 Digital therapeutics market driver impact
  • FIG. 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
  • FIG. 19 Top countries by smartphone users, 2021
  • FIG. 20 Digital therapeutics market restraint impact
  • FIG. 21 Market participation categorization
  • FIG. 22 Market leaders and innovators
  • FIG. 23 Company market position analysis
  • FIG. 24 Major deals & strategic alliances analysis
  • FIG. 25 COVID-19 confirmed cases around the world (March 2020- October 2021)
  • FIG. 26 Digital therapeutics market: Application movement analysis
  • FIG. 27 Digital therapeutics Market: Application dashboard
  • FIG. 28 Global diabetes market, 2018 - 2030 (USD Million)
  • FIG. 29 Global obesity market, 2018- 2030 (USD Million)
  • FIG. 30 Global CVD market, 2018- 2030 (USD Million)
  • FIG. 31 Global respiratory diseases market, 2018 - 2030 (USD Million)
  • FIG. 32 Global smoking cessation market, 2018 - 2030 (USD Million)
  • FIG. 33 Global CNS diseases market, 2018- 2030 (USD Million)
  • FIG. 34 Global others market, 2018- 2030 (USD Million)
  • FIG. 35 Digital therapeutics market: End-use movement analysis
  • FIG. 36 Digital therapeutics market: End-use dashboard
  • FIG. 37 Global patients market, 2018- 2030 (USD Million)
  • FIG. 38 Global providers market, 2018 - 2030 (USD Million)
  • FIG. 39 Global payers market, 2018 - 2030 (USD Million)
  • FIG. 40 Global employers market, 2018 - 2030 (USD Million)
  • FIG. 41 Global other end-user market, 2018- 2030 (USD Million)
  • FIG. 42 Regional marketplace: Key takeaways
  • FIG. 43 North America: SWOT analysis
  • FIG. 44 North America digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 45 U.S. digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 46 Canada digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 47 Europe: SWOT analysis
  • FIG. 48 Europe digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 49 UK digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 50 Germany digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 51 France digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 52 Italy digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 53 Spain digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 54 Sweden digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 55 Norway digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 56 Denmark digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 57 Asia Pacific: SWOT analysis
  • FIG. 58 Asia Pacific Digital Therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 59 Japan digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 60 China digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 61 India digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 62 Australia digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 63 South Korea digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • FIG. 64 Thailand digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • FIG. 65 Latin America: SWOT analysis
  • FIG. 66 Latin America digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 67 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 68 Brazil digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 69 Argentina digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 70 Middle East and Africa: SWOT analysis
  • FIG. 71 Middle East and Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 72 South Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 73 Saudi Arabia digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 74 UAE digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 75 Israel digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 76 Kuwait digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 77 Heat map analysis
  • FIG. 78 List of key emerging companies/technology disruptors/innovators